SCHEMBL9506665

SCHEMBL9506665

CS(=O)(=O)Nc1ccc(CC(N)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ HPGD P15428 2/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ ADRB2 P07550 3/20 0.49
▸ ADRB1 P08588 3/20 0.49
▸ ADRB3 P13945 3/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ GLA P06280 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ ADRA2C P18825 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ ADRA1B P35368 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11757925 0.84 PTPRB (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL1595806 0.82 SLC7A5 (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL1595807 0.82 SLC7A5 (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL11420231 0.81 NR3C1 (0.49) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL21635531 0.80 LMNA (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL16776722 0.80 LMNA (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL14338181 0.80 PTPRB (0.56) LMNAKDM4EHPGDALDH1A1HTT
SCHEMBL1596041 0.80 PTPRB (0.56) LMNAKDM4EHPGDALDH1A1HTT
Hydrochloric Acid SCHEMBL6420499 0.79 LMNA (0.55) LMNAKDM4EHPGDALDH1A1HTT
Hydrochloric Acid SCHEMBL1596038 0.79 PTPRB (0.55) LMNAKDM4EHPGDALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014080306-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES KANDULA MAHESH (IN) 2014-05-30 — — WO claimed
EP-0157409-A2 Renin inhibitors containing 2-substituted statine MERCK & CO. INC. (US) 1985-10-09 — — EP claimed
EP-0546115-A1 PEPTIDES CONTAINING AMINO-POLYOLS AS TRANSITION-STATE MIMICS THE UPJOHN COMPANY (US) 1993-06-16 — — EP disclosed
EP-0468998-A1 PEPTIDES HAVING NOVEL POLAR N-TERMINAL GROUPS THE UPJOHN COMPANY (US) 1992-02-05 — — EP disclosed
EP-0157409-A2 Renin inhibitors containing 2-substituted statine MERCK & CO. INC. (US) 1985-10-09 — — EP disclosed
EP-0129189-A2 Renin inhibitors containing a C-terminal amide cycle and compositions and combinations containing the same MERCK & CO. INC. (US) 1984-12-27 — — EP disclosed
Send feedback